Search
01/01/2023
Quality of life in pituitary diseases
Webb S.M., Valassi E.. Quality of life in pituitary diseases. Endocrinologia Diabetes y Nutricion. 2023; 70(7)DOI:10.1016/j.endinu.2023.03.001. PMID:. IF:(Q/D).
01/01/2023
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis
Reiniš J., Petrenko O., Simbrunner B., Hofer B.S., Schepis F., Scoppettuolo M., Saltini D., Indulti F., Guasconi T., Albillos A., Téllez L., Villanueva C., Brujats A., Garcia-Pagan J.C., Perez-Campuzano V., Hernández-Gea V., Rautou P.-E., Moga L., Vanwolleghem T., Kwanten W.J., Francque S., Trebicka J., Gu W., Ferstl P.G., Gluud L.L., Bendtsen F., Møller S., Kubicek S., Mandorfer M., Reiberger T.. Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis. JOURNAL OF HEPATOLOGY. 2023; 78(2)DOI:10.1016/j.jhep.2022.09.012. PMID:36152767. IF:26.800(Q1/1D).
01/01/2023
SEED Consensus Document on SpyGlass-DS
Sánchez-Ocaña R., Foruny Olcina J.R., Vila Costas J., Gallego Rojo F., Jiménez Pérez J., Domínguez-Muñoz E., González Huix F., Pons Beltrán V., Gornals Soler J., Sánchez Hernández E., Gómez Oliva C., Dolz Abadía C., Aparicio Tormo J.R.. SEED Consensus Document on SpyGlass-DS. Gastroenterologia y Hepatologia. 2023; 46(1)DOI:10.1016/j.gastrohep.2022.08.012. PMID:36179947. IF:2.200(Q3/6D).
01/01/2023
Position paper of the Catalan Society of Gastroenterology about hepatic elastography 2022
Carrión J.A., Graupera I., Vergara M., Morillas R.M., Pericàs J.M., Poca M., Amador A., Fernández R., Monllor T., Muñoz L., Bartres C., Genescà J., Ginés P., Forns X.. Position paper of the Catalan Society of Gastroenterology about hepatic elastography 2022. Gastroenterologia y Hepatologia. 2023; 46(9)DOI:10.1016/j.gastrohep.2022.11.005. PMID:36435378. IF:2.200(Q3/6D).
01/01/2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
Chaparro M., Acosta D., Rodríguez C., Mesonero F., Vicuña M., Barreiro-De Acosta M., Fernández-Clotet A., Hernández Martínez Á., Arroyo M., Vera I., Ruiz-Cerulla A., Sicilia B., Cabello Tapia M.J., Muñoz Villafranca C., Castro-Poceiro J., Martínez Cadilla J., Sierra-Ausín M., Vázquez Morón J.M., Vicente Lidón R., Bermejo F., Royo V., Calafat M., González-Muñoza C., Leo Carnerero E., Manceñido Marcos N., Torrealba L., Alonso-Galán H., Benítez J.M., Ber Nieto Y., Diz-Lois Palomares M.T., García M.J., Muñoz J.F., Armesto González E.M., Calvet X., Hernández-Camba A., Madrigal Domínguez R.E., Menchén L., Pérez Calle J.L., Piqueras M., Dueñas Sadornil C., Botella B., Martínez-Pérez T.D.J., Ramos L., Rodríguez-Grau M.C., San Miguel E., Fernández Forcelledo J.L., Fradejas Salazar P.M., García-Sepulcre M., Gutiérrez A., Llaó J., Sesé Abizanda E., Boscá-Watts M., Iyo E., Keco-Huerga A., Martínez Bonil C., Peña González E., Pérez-Galindo P., Varela P., Gisbert J.P.. Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2023; 118(7)DOI:10.14309/ajg.0000000000002145. PMID:36716287. IF:8.500(Q1/1D).
01/01/2023
Carvedilol, probably the ß-blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!
Villanueva C., Tripathi D.. Carvedilol, probably the ß-blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!. LIVER INTERNATIONAL. 2023; 43(6)DOI:10.1111/liv.15582. PMID:37166136. IF:6.000(Q1/2D).
01/01/2023
Usefulness of Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in the Characterization of Leishmania Strains Causing Tegumentary Leishmaniasis in Bolivia versus hsp70 Gene Sequencing
Torrico M.C., Fernández-Arévalo A., Ballart C., Solano M., Rojas E., Abras A., Gonzales F., Arnau A., Tebar S., Llovet T., Lozano D., Ariza-Vioque E., Gascón J., Picado A., Torrico F., Munoz, C, Gállego M.. Usefulness of Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in the Characterization of Leishmania Strains Causing Tegumentary Leishmaniasis in Bolivia versus hsp70 Gene Sequencing. Microbiology Spectrum. 2023; 11(1)DOI:10.1128/spectrum.03477-22. PMID:36633426. IF:3.700(Q2/4D).
01/01/2023
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)
Becerra-Aparicio F., Gómez-Zorrilla S., Hernández-García M., Gijón D., Siverio A., Berbel D., Sánchez-Carrillo C., Cercenado E., Rivera A., de Malet A., Xercavins M., Ruiz de Gopegui E., Canoura-Fernández L., Martínez J.A., Seral C., Del Pozo J.L., Cotarelo M., Díaz-Regañón J., Cantón R., Oliver A., Horcajada J.P., Ruiz-Garbajosa P.. Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(9)DOI:10.1093/jac/dkad234. PMID:37533351. IF:3.900(Q1/3D).